Literature DB >> 26827965

Primary site assignment in tubo-ovarian high-grade serous carcinoma: Consensus statement on unifying practice worldwide.

Naveena Singh1, C Blake Gilks2, Lynn Hirschowitz3, Sean Kehoe4, Iain A McNeish5, Dianne Miller6, Raj Naik7, Nafisa Wilkinson8, W Glenn McCluggage9.   

Abstract

Entities:  

Keywords:  Fallopian tube; High-grade serous carcinoma; Origin; Ovary; Pathology; Primary peritoneal carcinoma

Mesh：

Year:  2016        PMID： 26827965     DOI： 10.1016/j.ygyno.2015.10.022

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN： 0090-8258            Impact factor:   5.482


× No keyword cloud information.
  14 in total

1.  Somatic genetic alterations in synchronous and metachronous low-grade serous tumours and high-grade carcinomas of the adnexa.

Authors:  Rajmohan Murali; Pier Selenica; David N Brown; R Keira Cheetham; Raghu Chandramohan; Nidia L Claros; Nancy Bouvier; Donavan T Cheng; Robert A Soslow; Britta Weigelt; W Glenn McCluggage
Journal:  Histopathology       Date:  2019-01-15       Impact factor: 5.087

2.  Extrauterine high-grade serous carcinomas with bilateral adnexal involvement as the only two disease sites are clonal based on tp53 sequencing results: implications for biology, classification, and staging.

Authors:  Naveena Singh; Asma Faruqi; Friedrich Kommoss; W Glenn McCluggage; Giorgia Trevisan; Janine Senz; Amy Lum; C Blake Gilks; Michael Anglesio
Journal:  Mod Pathol       Date:  2017-11-17       Impact factor: 7.842

3.  Epigenetic therapy activates type I interferon signaling in murine ovarian cancer to reduce immunosuppression and tumor burden.

Authors:  Meredith L Stone; Katherine B Chiappinelli; Huili Li; Lauren M Murphy; Meghan E Travers; Michael J Topper; Dimitrios Mathios; Michael Lim; Ie-Ming Shih; Tian-Li Wang; Chien-Fu Hung; Vipul Bhargava; Karla R Wiehagen; Glenn S Cowley; Kurtis E Bachman; Reiner Strick; Pamela L Strissel; Stephen B Baylin; Cynthia A Zahnow
Journal:  Proc Natl Acad Sci U S A       Date:  2017-12-04       Impact factor: 11.205

4.  Reported Incidence and Survival of Fallopian Tube Carcinomas: A Population-Based Analysis From the North American Association of Central Cancer Registries.

Authors:  Britton Trabert; Sally B Coburn; Andrea Mariani; Hannah P Yang; Philip S Rosenberg; Gretchen L Gierach; Nicolas Wentzensen; Kathy A Cronin; Mark E Sherman
Journal:  J Natl Cancer Inst       Date:  2018-07-01       Impact factor: 13.506

5.  CRISPR/Cas9-Mediated Trp53 and Brca2 Knockout to Generate Improved Murine Models of Ovarian High-Grade Serous Carcinoma.

Authors:  Josephine Walton; Julianna Blagih; Darren Ennis; Elaine Leung; Suzanne Dowson; Malcolm Farquharson; Laura A Tookman; Clare Orange; Dimitris Athineos; Susan Mason; David Stevenson; Karen Blyth; Douglas Strathdee; Frances R Balkwill; Karen Vousden; Michelle Lockley; Iain A McNeish
Journal:  Cancer Res       Date:  2016-08-16       Impact factor: 12.701

Review 6.  Ovarian cancer.

Authors:  Ursula A Matulonis; Anil K Sood; Lesley Fallowfield; Brooke E Howitt; Jalid Sehouli; Beth Y Karlan
Journal:  Nat Rev Dis Primers       Date:  2016-08-25       Impact factor: 52.329

7.  Reduced PAX2 expression in murine fallopian tube cells enhances estrogen receptor signaling.

Authors:  Jose A Colina; Peter Varughese; Subbulakshmi Karthikeyan; Amrita Salvi; Dimple A Modi; Joanna E Burdette
Journal:  Carcinogenesis       Date:  2020-07-10       Impact factor: 4.944

8.  Ovarian Mesonephric-like Adenocarcinoma With Multifocal Microscopic Involvement of the Fimbrial Surface: Potential for Misdiagnosis of Tubal Intraepithelial Metastasis as Serous Tubal Intraepithelial Carcinoma Associated With Ovarian High-grade Serous Carcinoma.

Authors:  Hyunjin Kim; Go Eun Bae; Yoon Yang Jung; Hyun-Soo Kim
Journal:  In Vivo       Date:  2021 Nov-Dec       Impact factor: 2.155

Review 9.  Progress in the pathological arena of gynecological cancers.

Authors:  W Glenn McCluggage
Journal:  Int J Gynaecol Obstet       Date:  2021-10       Impact factor: 4.447

10.  SEOM Clinical Guideline in ovarian cancer (2016).

Authors:  A Santaballa; P Barretina; A Casado; Y García; A González-Martín; E Guerra; N Laínez; J Martinez; A Redondo; I Romero
Journal:  Clin Transl Oncol       Date:  2016-11-30       Impact factor: 3.405
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.